The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global fetal and neonatal care equipment market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 7.12% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The fetal and neonatal care (FNC) equipment are specialized devices that are used to diagnose, monitor and treat diseases and medical ailments of the fetus and newborn babies. These devices are crucial for routine check-ups in gynecology and obstetrics interventions. Ultrasound devices, fetal dopplers, fetal MRI systems, incubators, phototherapy and respiratory devices are some of the most extensively utilized FNC equipment. They also find applications in the Neonatal Intensive Care Units (NICUs) for the treatment of ailments, including anemia, bronchopulmonary dysplasia, intraventricular hemorrhage, hyperbilirubinemia and transient tachypnea.
The increasing prevalence of hospital-acquired neonatal ailments and complications is one of the key factors driving the growth of the market. Furthermore, the rising cases of premature birth with low immunity and weight are contributing to the increasing requirement of FNC equipment across the globe. Maternal and fetal care is rapidly becoming a global priority to prevent fatalities during pregnancy and childbirth. Additionally, technological advancements and innovations in patient monitoring, respiratory, and phototherapy devices aimed at making them more user-friendly, cost-effective and highly accurate, are providing a boost to the market. Moreover, equipment features such as light-weight, compact designs and remote monitoring facilities are further increasing product adoption in medical institutions. Other factors, including improving fertility rate, efforts by both government and non-government organizations (NGOs) to create awareness for fetal and neonatal care and extensive research and development (R&D), are projected to drive the market further.
Breakup by Product Type:
Breakup by End-User:
Breakup by Region
The competitive landscape of the industry has also been examined with some of the key players being ArjoHuntleigh, Atom Medical Corporation, Becton Dickinson, Covidien, Drägerwerk, Fisher & Paykel, GE Healthcare, Masimo, Medtronic PLC, Natus Medical Incorporated, Philips Healthcare, Phoenix Medical Systems, Smiths Medical, Spacelabs Healthcare, Utah Medical Products, Vyaire Medical Inc., etc.
|Base Year of the Analysis||2020|
|Segment Coverage||Product Type, End-User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico, Argentina, Columbia, Chile, Peru, Turkey, Saudi Arabia, Iran, United Arab Emirates,|
|Companies Covered||ArjoHuntleigh, Atom Medical Corporation, Becton Dickinson, Covidien, Drägerwerk, Fisher & Paykel, GE Healthcare, Masimo, Medtronic PLC, Natus Medical Incorporated, Philips Healthcare, Phoenix Medical Systems, Smiths Medical, Spacelabs Healthcare, Utah Medical Products, Vyaire Medical Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at